Schistosomiasis Drugs Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Schistosomiasis Drugs Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Insights into the Schistosomiasis Drugs Market include supply chain optimization, Schistosomiasis Drugs challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report describes the global market size of Schistosomiasis Drugs from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.
For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Schistosomiasis Drugs as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share
Applications Segment:
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Types Segment:
Praziquantel
Oxamniquine
Other
Companies Covered:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
etc.
Please ask for sample pages for full companies list
Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026
Any special requirements about this report, please let us know and we can provide custom report.
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Schistosomiasis Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Schistosomiasis Drugs Market in North America (2016-2026)
8.1 Schistosomiasis Drugs Market Size
8.2 Schistosomiasis Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Schistosomiasis Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Schistosomiasis Drugs Market in South America (2016-2026)
9.1 Schistosomiasis Drugs Market Size
9.2 Schistosomiasis Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Schistosomiasis Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Schistosomiasis Drugs Market in Asia & Pacific (2016-2026)
10.1 Schistosomiasis Drugs Market Size
10.2 Schistosomiasis Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Schistosomiasis Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Schistosomiasis Drugs Market in Europe (2016-2026)
11.1 Schistosomiasis Drugs Market Size
11.2 Schistosomiasis Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Schistosomiasis Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Schistosomiasis Drugs Market in MEA (2016-2026)
12.1 Schistosomiasis Drugs Market Size
12.2 Schistosomiasis Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Schistosomiasis Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Schistosomiasis Drugs Market (2016-2021)
13.1 Schistosomiasis Drugs Market Size
13.2 Schistosomiasis Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Schistosomiasis Drugs Market Size by Type
Chapter 14 Global Schistosomiasis Drugs Market Forecast (2021-2026)
14.1 Schistosomiasis Drugs Market Size Forecast
14.2 Schistosomiasis Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Schistosomiasis Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Shin Poong
15.1.1 Company Profile
15.1.2 Main Business and Schistosomiasis Drugs Information
15.1.3 SWOT Analysis of Shin Poong
15.1.4 Shin Poong Schistosomiasis Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.2 Merck
15.2.1 Company Profile
15.2.2 Main Business and Schistosomiasis Drugs Information
15.2.3 SWOT Analysis of Merck
15.2.4 Merck Schistosomiasis Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.3 Bayer
15.3.1 Company Profile
15.3.2 Main Business and Schistosomiasis Drugs Information
15.3.3 SWOT Analysis of Bayer
15.3.4 Bayer Schistosomiasis Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.4 EIPICO
15.4.1 Company Profile
15.4.2 Main Business and Schistosomiasis Drugs Information
15.4.3 SWOT Analysis of EIPICO
15.4.4 EIPICO Schistosomiasis Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.5 Chandra Bhagat Pharma
15.5.1 Company Profile
15.5.2 Main Business and Schistosomiasis Drugs Information
15.5.3 SWOT Analysis of Chandra Bhagat Pharma
15.5.4 Chandra Bhagat Pharma Schistosomiasis Drugs Revenue, Gross Margin and Market Share (2016-2021)
15.6 Taj Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and Schistosomiasis Drugs Information
15.6.3 SWOT Analysis of Taj Pharmaceuticals
15.6.4 Taj Pharmaceuticals Schistosomiasis Drugs Revenue, Gross Margin and Market Share (2016-2021)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Schistosomiasis Drugs Report
Table Data Sources of Schistosomiasis Drugs Report
Table Major Assumptions of Schistosomiasis Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Schistosomiasis Drugs Picture
Table Schistosomiasis Drugs Classification
Table Schistosomiasis Drugs Applications
Table Drivers of Schistosomiasis Drugs Market
Table Restraints of Schistosomiasis Drugs Market
Table Opportunities of Schistosomiasis Drugs Market
Table Threats of Schistosomiasis Drugs Market
Table Covid-19 Impact For Schistosomiasis Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Schistosomiasis Drugs
Table Cost Structure Analysis of Schistosomiasis Drugs
Table Key End Users
Table Latest News of Schistosomiasis Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Schistosomiasis Drugs Market
Table Policy of Schistosomiasis Drugs Market
Table 2016-2026 North America Schistosomiasis Drugs Market Size
Figure 2016-2026 North America Schistosomiasis Drugs Market Size and CAGR
Table 2016-2026 North America Schistosomiasis Drugs Market Size by Application
Table 2016-2021 North America Schistosomiasis Drugs Key Players Revenue
Table 2016-2021 North America Schistosomiasis Drugs Key Players Market Share
Table 2016-2026 North America Schistosomiasis Drugs Market Size by Type
Table 2016-2026 United States Schistosomiasis Drugs Market Size
Table 2016-2026 Canada Schistosomiasis Drugs Market Size
Table 2016-2026 Mexico Schistosomiasis Drugs Market Size
Table 2016-2026 South America Schistosomiasis Drugs Market Size
Figure 2016-2026 South America Schistosomiasis Drugs Market Size and CAGR
Table 2016-2026 South America Schistosomiasis Drugs Market Size by Application
Table 2016-2021 South America Schistosomiasis Drugs Key Players Revenue
Table 2016-2021 South America Schistosomiasis Drugs Key Players Market Share
Table 2016-2026 South America Schistosomiasis Drugs Market Size by Type
Table 2016-2026 Brazil Schistosomiasis Drugs Market Size
Table 2016-2026 Argentina Schistosomiasis Drugs Market Size
Table 2016-2026 Chile Schistosomiasis Drugs Market Size
Table 2016-2026 Peru Schistosomiasis Drugs Market Size
Table 2016-2026 Asia & Pacific Schistosomiasis Drugs Market Size
Figure 2016-2026 Asia & Pacific Schistosomiasis Drugs Market Size and CAGR
Table 2016-2026 Asia & Pacific Schistosomiasis Drugs Market Size by Application
Table 2016-2021 Asia & Pacific Schistosomiasis Drugs Key Players Revenue
Table 2016-2021 Asia & Pacific Schistosomiasis Drugs Key Players Market Share
Table 2016-2026 Asia & Pacific Schistosomiasis Drugs Market Size by Type
Table 2016-2026 China Schistosomiasis Drugs Market Size
Table 2016-2026 India Schistosomiasis Drugs Market Size
Table 2016-2026 Japan Schistosomiasis Drugs Market Size
Table 2016-2026 South Korea Schistosomiasis Drugs Market Size
Table 2016-2026 Southeast Asia Schistosomiasis Drugs Market Size
Table 2016-2026 Australia Schistosomiasis Drugs Market Size
Table 2016-2026 Europe Schistosomiasis Drugs Market Size
Figure 2016-2026 Europe Schistosomiasis Drugs Market Size and CAGR
Table 2016-2026 Europe Schistosomiasis Drugs Market Size by Application
Table 2016-2021 Europe Schistosomiasis Drugs Key Players Revenue
Table 2016-2021 Europe Schistosomiasis Drugs Key Players Market Share
Table 2016-2026 Europe Schistosomiasis Drugs Market Size by Type
Table 2016-2026 Germany Schistosomiasis Drugs Market Size
Table 2016-2026 France Schistosomiasis Drugs Market Size
Table 2016-2026 United Kingdom Schistosomiasis Drugs Market Size
Table 2016-2026 Italy Schistosomiasis Drugs Market Size
Table 2016-2026 Spain Schistosomiasis Drugs Market Size
Table 2016-2026 Belgium Schistosomiasis Drugs Market Size
Table 2016-2026 Netherlands Schistosomiasis Drugs Market Size
Table 2016-2026 Austria Schistosomiasis Drugs Market Size
Table 2016-2026 Poland Schistosomiasis Drugs Market Size
Table 2016-2026 Russia Schistosomiasis Drugs Market Size
Table 2016-2026 MEA Schistosomiasis Drugs Market Size
Figure 2016-2026 MEA Schistosomiasis Drugs Market Size and CAGR
Table 2016-2026 MEA Schistosomiasis Drugs Market Size by Application
Table 2016-2021 MEA Schistosomiasis Drugs Key Players Revenue
Table 2016-2021 MEA Schistosomiasis Drugs Key Players Market Share
Table 2016-2026 MEA Schistosomiasis Drugs Market Size by Type
Table 2016-2026 Egypt Schistosomiasis Drugs Market Size
Table 2016-2026 Israel Schistosomiasis Drugs Market Size
Table 2016-2026 South Africa Schistosomiasis Drugs Market Size
Table 2016-2026 Gulf Cooperation Council Countries Schistosomiasis Drugs Market Size
Table 2016-2026 Turkey Schistosomiasis Drugs Market Size
Table 2016-2021 Global Schistosomiasis Drugs Market Size by Region
Table 2016-2021 Global Schistosomiasis Drugs Market Size Share by Region
Table 2016-2021 Global Schistosomiasis Drugs Market Size by Application
Table 2016-2021 Global Schistosomiasis Drugs Market Share by Application
Table 2016-2021 Global Schistosomiasis Drugs Key Vendors Revenue
Figure 2016-2021 Global Schistosomiasis Drugs Market Size and Growth Rate
Table 2016-2021 Global Schistosomiasis Drugs Key Vendors Market Share
Table 2016-2021 Global Schistosomiasis Drugs Market Size by Type
Table 2016-2021 Global Schistosomiasis Drugs Market Share by Type
Table 2021-2026 Global Schistosomiasis Drugs Market Size by Region
Table 2021-2026 Global Schistosomiasis Drugs Market Size Share by Region
Table 2021-2026 Global Schistosomiasis Drugs Market Size by Application
Table 2021-2026 Global Schistosomiasis Drugs Market Share by Application
Table 2021-2026 Global Schistosomiasis Drugs Key Vendors Revenue
Figure 2021-2026 Global Schistosomiasis Drugs Market Size and Growth Rate
Table 2021-2026 Global Schistosomiasis Drugs Key Vendors Market Share
Table 2021-2026 Global Schistosomiasis Drugs Market Size by Type
Table 2021-2026 Schistosomiasis Drugs Global Market Share by Type
Research Methodology:
Schistosomiasis Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|